Frank Clyburn - 05 Aug 2024 Form 4/A - Amendment Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Frank Clyburn
Issuer symbol
RVMD
Transactions as of
05 Aug 2024
Net transactions value
$0
Form type
4/A - Amendment
Filing time
28 Apr 2025, 18:27:35 UTC
Date Of Original Report
07 Aug 2024
Previous filing
05 Mar 2024
Next filing
01 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Award $0 +26,540 $0.000000 26,540 05 Aug 2024 Common Stock 26,540 $42.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.

Remarks:

On August 5, 2024, the Reporting Person filed a Form 4 that inadvertently reported incorrect amount for the Stock Option award granted to the Reporting Person on August 5, 2024. The correct amount is reflected in this amendment.